registered medications for indications not specified in the instructions for medical use provided that there is a proven efficacy in the treatment of coronavirus disease (COVID-19) and/or if such medications are recommended by an official authority of the United States, member states of the European Union, Great Britain, Swiss Confederation, Japan, Australia, Canada, the People's Republic of China, the State of Israel for the treatment of coronavirus disease (COVID-19) in the respective country.